514 related articles for article (PubMed ID: 7854378)
41. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
[TBL] [Abstract][Full Text] [Related]
42. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
[TBL] [Abstract][Full Text] [Related]
43. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use.
Lazarus P; Stern J; Zwiebel N; Fair A; Richie JP; Schantz S
Carcinogenesis; 1996 Apr; 17(4):733-9. PubMed ID: 8625484
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Lindenbergh-van der Plas M; Brakenhoff RH; Kuik DJ; Buijze M; Bloemena E; Snijders PJ; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2011 Jun; 17(11):3733-41. PubMed ID: 21467160
[TBL] [Abstract][Full Text] [Related]
45. TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil.
Rossini A; de Almeida Simão T; Marques CB; Soares-Lima SC; Herbster S; Rapozo DC; Andreollo NA; Ferreira MA; El-Jaick KB; Teixeira R; Guimarães DP; Albano RM; Ribeiro Pinto LF
Mutat Res; 2010 Feb; 696(1):10-5. PubMed ID: 19944185
[TBL] [Abstract][Full Text] [Related]
46. p53--master and commander.
Foulkes WD
N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
[No Abstract] [Full Text] [Related]
47. Genomic profiling of sinonasal squamous cell carcinoma.
López F; Llorente JL; García-Inclán C; Alonso-Guervós M; Cuesta-Albalad MP; Fresno MF; Alvarez-Marcos C; Suárez C; Hermsen MA
Head Neck; 2011 Feb; 33(2):145-53. PubMed ID: 20848437
[TBL] [Abstract][Full Text] [Related]
48. Head and neck cancer: response to p53-based therapeutics.
Nemunaitis J; Nemunaitis J
Head Neck; 2011 Jan; 33(1):131-4. PubMed ID: 20222046
[TBL] [Abstract][Full Text] [Related]
49. Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.
Ickstadt K; Schäfer M; Fritsch A; Schwender H; Abel J; Bolt HM; Brüning T; Ko YD; Vetter H; Harth V
J Toxicol Environ Health A; 2008; 71(11-12):803-15. PubMed ID: 18569579
[TBL] [Abstract][Full Text] [Related]
50. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck.
Field JK; Pavelic ZP; Spandidos DA; Stambrook PJ; Jones AS; Gluckman JL
Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1118-22. PubMed ID: 8398063
[TBL] [Abstract][Full Text] [Related]
51. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
[TBL] [Abstract][Full Text] [Related]
52. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
[TBL] [Abstract][Full Text] [Related]
53. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value.
Bosch FX; Ritter D; Enders C; Flechtenmacher C; Abel U; Dietz A; Hergenhahn M; Weidauer H
Int J Cancer; 2004 Sep; 111(4):530-8. PubMed ID: 15239130
[TBL] [Abstract][Full Text] [Related]
54. The International Head and Neck Cancer Epidemiology consortium.
Sturgis EM
Head Neck; 2011 Jan; 33(1):141. PubMed ID: 21225903
[No Abstract] [Full Text] [Related]
55. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
56. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.
Temam S; Flahault A; Périé S; Monceaux G; Coulet F; Callard P; Bernaudin JF; St Guily JL; Fouret P
J Clin Oncol; 2000 Jan; 18(2):385-94. PubMed ID: 10637254
[TBL] [Abstract][Full Text] [Related]
57. ΔNp63α/IRF6 interplay activates NOS2 transcription and induces autophagy upon tobacco exposure.
Ratovitski EA
Arch Biochem Biophys; 2011 Feb; 506(2):208-15. PubMed ID: 21129360
[TBL] [Abstract][Full Text] [Related]
58. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Lai S; Luna MA; Zhou XD; Weber RS; Goepfert H; Batsakis JG
Int J Cancer; 1995 Jun; 64(3):196-201. PubMed ID: 7622308
[TBL] [Abstract][Full Text] [Related]
59. p53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users.
Lazarus P; Idris AM; Kim J; Calcagnotto A; Hoffmann D
Cancer Detect Prev; 1996; 20(4):270-8. PubMed ID: 8818386
[TBL] [Abstract][Full Text] [Related]
60. TP53 genetic alterations in head-and-neck carcinomas from Brazil.
Nagai MA; Miracca EC; Yamamoto L; Moura RP; Simpson AJ; Kowalski LP; Brentani RR
Int J Cancer; 1998 Mar; 76(1):13-8. PubMed ID: 9533755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
